| | | | | | | |
 | MODERNA, INC. | 4.42% | 7.53% | -43.98% | -11.31% | 516.46% | 56 593 |
 | LONZA GROUP AG | -0.47% | 5.50% | -27.76% | -2.31% | 77.20% | 41 313 |
| IQVIA HOLDINGS INC. | 0.12% | 1.71% | -26.74% | -10.71% | 54.63% | 39 122 |
| SEAGEN INC. | 2.81% | 21.64% | -5.21% | -0.97% | 120.64% | 26 976 |
| ICON PUBLIC LIMITED COMPANY | -0.65% | -0.38% | -32.47% | -7.35% | 52.14% | 17 002 |
| ALNYLAM PHARMACEUTICALS, INC. | 3.56% | 1.92% | -23.75% | -4.84% | 91.46% | 15 622 |
 | CELLTRION, INC. | 1.06% | -12.04% | -28.03% | -46.07% | -20.37% | 15 600 |
| BIO-TECHNE CORPORATION | 2.46% | 5.55% | -28.28% | -4.21% | 87.91% | 14 558 |
 | PHARMARON BEIJING CO., LTD. | 0.16% | -3.16% | -20.83% | -36.59% | 216.77% | 12 464 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | 2.17% | 3.04% | -37.31% | -26.80% | 83.00% | 12 001 |
| HANGZHOU TIGERMED CONSULTING CO., LTD | 1.61% | 0.81% | -31.77% | -46.18% | 87.45% | 10 762 |
| QIAGEN N.V. | -0.99% | 2.57% | -17.43% | -1.73% | 23.79% | 10 438 |
| BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. | 0.84% | 1.27% | 2.88% | 101.76% | 129.38% | 10 073 |
| UNITED THERAPEUTICS CORPORATION | 3.17% | 6.63% | -11.61% | -3.68% | 110.69% | 8 652 |
| SYNEOS HEALTH, INC. | 1.96% | 1.32% | -30.53% | -16.48% | 72.17% | 7 317 |
| | | | | | | |
| | Moyenne | 1.48% | 2.93% | -24.19% | -7.83% | 113.55% | |
| | Moyenne pondérée par Capi. | 1.65% | 4.47% | -27.20% | -8.65% | 163.36% | |
English (USA)
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Italiano
Nederlands (Nederland)
Nederlands (België)
bourse
Rapport
